SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (December 19, 2001):
Medical Technology and Innovations Inc.
(Exact Name of Registrant as Specified in Charter)
Florida 33-27610-A 65-2954561
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
80 Abbeyville Road
Lancaster Pennsylvania 17603
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: 717-390-0352
NOT APPLICABLE
(Former Name or Former Address, if Changed Since Last Report)
Item 1. Changes In Control Of Registrant
Not Applicable.
Item 2. Acquisition Or Disposition Of Assets
Not Applicable.
Item 3. Bankruptcy or Receivership
Not Applicable
Item 4. Changes in Registrant's Certifying Accountant
Not Applicable.
Item 5. Other Events and Regulation FD Disclosure
The Company's Board of Directors unanimously approved a reverse stock split of
the Company's common stock at a ratio of one (1) share for twenty-five (25)
shares. The reverse split became effective on December 4th, 2001. After the
split, the Company has 3,365,131 shares of common stock issued and outstanding.
Prior to the split, the Company had 84,128,298 shares of Common Stock
outstanding.
The Company reduced its authorized capital shares in proportion to the reverse
split. The authorized capital stock of the Company consists of 28,000,000 shares
of common stock. Prior to the split, the Company was authorized to issue
700,000,000 shares of common stock.
The Company's Board of Directors also unanimously approved a change of the
Company's trading symbol. The Company's new trading symbol is OTC Bulletin Board
symbol "MTIV."
Item 6. Resignations of Registrant's Directors.
Not Applicable.
Item 7. Financial Statements, Pro Forma Financial Information And Exhibits
Not Applicable.
Item 8. Change In Fiscal Year.
Not Applicable.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDICAL TECHNOLOGY and INNOVATIONS, INC.
Date: December 19, 2001
By:/s/ Jeremy Feakins
Chairman and Chief Executive Officer
